WallStreetZenWallStreetZen

NASDAQ: SUPN
Supernus Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Supernus Pharmaceuticals earnings were $73.9M for the trailing 12 months ending Dec 31, 2024, with 6,600% growth year over year. The latest SUPN earnings report on Dec 31, 2024 announced Q4 2024 earnings of $15.3M, down 60.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SUPN reported annual earnings of $73.9M, with 5,512.8% growth. The next SUPN earnings date is May 6, 2025.

SUPN past earnings growth

How has SUPN's earnings growth performed historically?

Company
6,600%
Industry
55.42%
Market
65.38%
SUPN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SUPN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SUPN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SUPN earnings history

Current Revenue
$661.8M
Current Earnings
$73.9M
Current Profit Margin
11.2%

SUPN Return on Equity

Current Company
7.5%
Current Industry
12.5%
Current Market
34.1%
SUPN's Return on Equity (7.5%)... subscribe to Premium to read more.
High Return on Equity Performance

SUPN undefined

Current Company
5.5%
Current Industry
5.5%
SUPN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SUPN announces earnings.

SUPN undefined

Current Company
9.1%
Current Industry
12%
SUPN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SUPN vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SUPN$178.28M$73.87M-9.11%$1.34
BHC$2.85B-$46.00MN/A-$0.13
ANIP$64.65M-$20.15MN/A-$1.04
EVO-$89.62M-$217.86MN/A-$0.62
DVAX$45.70M$27.31M-87.12%$0.21
View Top Pharmaceutical Stocks

SUPN earnings dates

Next earnings date
May 6, 2025

Supernus Pharmaceuticals Earnings Reports & History FAQ

What were Supernus Pharmaceuticals's earnings last quarter?

On SUPN's earnings call on Invalid Date, Supernus Pharmaceuticals (NASDAQ: SUPN) reported Q4 2024 earnings per share (EPS) of $0.28, up 1,300% year over year. Total SUPN earnings for the quarter were $15.33 million. In the same quarter last year, Supernus Pharmaceuticals's earnings per share (EPS) was $0.02.

If you're new to stock investing, here's how to buy Supernus Pharmaceuticals stock.

When does Supernus Pharmaceuticals report earnings?

The next SUPN earnings call is Invalid Date. Add SUPN to your watchlist to be reminded of Supernus Pharmaceuticals's next earnings date.

Is Supernus Pharmaceuticals profitable or losing money?

As of the last Supernus Pharmaceuticals earnings report, Supernus Pharmaceuticals is currently profitable. Supernus Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $73.87 million, a 5,512.84% increase year over year.

What was SUPN's earnings growth in the past year?

As of Supernus Pharmaceuticals's earnings date in Invalid Date, Supernus Pharmaceuticals's earnings has grown 6,600% year over year. This is 6,544.58 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 55.42%. SUPN earnings in the past year totalled $73.87 million.

What are Supernus Pharmaceuticals's earnings expectations?

The current EPS estimate for Supernus Pharmaceuticals's earnings report in Invalid Date is $0.38.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.